Commentary: Upsizing the Potential Performance of Pulmonary Valve Prostheses

  • Jeremy L. Herrmann
    Address reprint requests to Jeremy L. Herrmann, MD, 545 Barnhill Drive, Emerson 215, Indianapolis, Indiana 46202.
    Indiana University School of Medicine, Indianapolis, Indiana

    Riley Children's Health at Indiana University School of Medicine, Indianapolis, Indiana
    Search for articles by this author
      Using large stented porcine bioprosthetic valves for pulmonary valve replacement may yield good long-term results. Comparative data between valve options are still lacking, however.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Seminars in Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Maeda K.
        • Lui G.K.
        • Zhang Y.
        • et al.
        Durability of pulmonary valve replacement with large diameter stented porcine bioprostheses.
        Semin Thorac Cardiovasc Surg. 2022; 34: 994-1000
        • Kasten M.W.
        • Herrmann J.L.
        • Cox M.
        • et al.
        Two decades using stentless porcine aortic root in right ventricular outflow tract reconstruction.
        Ann Thorac Surg. 2020; (Online ahead of print)

      Linked Article

      • Durability of Pulmonary Valve Replacement with Large Diameter Stented Porcine Bioprostheses
        Seminars in Thoracic and Cardiovascular SurgeryVol. 34Issue 3
        • Preview
          There is limited information about durability of large diameter porcine bioprostheses implanted for pulmonary valve replacement (PVR). We studied patients who underwent surgical PVR from 2002-2019 with a stented porcine bioprosthetic valve (BPV) with a labeled size ≥27 mm. The primary outcome was freedom from reintervention. During the study period, 203 patients underwent PVR using a porcine BPV ≥27 mm, 94% of whom received a Mosaic valve (Medtronic Inc., Minneapolis, MN). Twenty patients underwent reintervention from 3.4-12.0 years after PVR: 5 surgical and 15 transcatheter PVR procedures.
        • Full-Text
        • PDF